Premenstrual Syndrome (PMS)

DBCOND0066800Mental DisordersNervous system physiological phenomena

Premenstrual Syndrome (PMS) is the indication for 4 drugs in DrugBank. It is covered by 5 curated, structured indications.

Also known as
PMS · Premenstrual Syndrome · Premenstrual Syndrome-PMS · pre-menstrual syndrome
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0017534ICD-10N94.3SNOMED CT123076003MedDRA10035634UMLSC0033046

What you can answer from here — as of October 25, 2026

4Indicated drugsWith each drug's targets and mechanism
Listed above
5Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
48Clinical trialsPhase, status and sponsor resolved per trial
Sign in
10Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Premenstrual Syndrome (PMS) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In